2014-2026 Global Chronic Kidney Disease (CKD) Drug Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region
SKU ID : Maia-14981783 | Publishing Date : 10-Dec-2019 | No. of pages : 130
The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in
Major Region
s, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.Major Companies Covered
Reata Pharmaceuticals
Cara Therapeutics
Regulus Therapeutics
Amgen Inc.
ZS Pharma
Keryx Biopharmaceuticals
Raptor Pharmaceuticals
FibroGen
Akebia Therapeutics
Shield Therapeutics
Sanofi
F. Hoffmann-La Roche Ltd
AMAG Pharmaceuticals
Rockwell Medical
Abbott Laboratories
Actavis PLC
OPKO Health
Johnson & Johnson
Vifor Pharma Ltd
Takeda Pharmaceuticals
Pharmacosmos
Xenetic Biosciences
Major Types Covered
ACE Inhibitors
Angiotensin-II receptor blockers
Calcium channel blockers
Beta blockers
Erythropoiesis-stimulating agents (ESAs)
Diuretics
Others
Major Applications Covered
Hospitals
Specialty Clinics
Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
…
Years considered for this report:
Historical Years:
2014-2018Base Year:
2019Estimated Year:
2019Forecast Period:
2019-2026Frequently Asked Questions
- By product type
- By End User/Applications
- By Technology
- By Region